Bacterial Prevalence and Antibiotic Resistance Patterns in Acute Exacerbation of COPD Patients Admitted to the Intensive Care Unit in a Tertiary Care Hospital in Uttarakhand: A Retrospective Study
DOI:
https://doi.org/10.51168/x2b6m266Cuvinte cheie:
Acute exacerbation of COPD, bacterial infection, antibiotic resistance, antensive care unit, sputum culture, multidrug resistanceRezumat
Background:
Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a common cause of intensive care unit (ICU) admission, respiratory failure, prolonged hospitalization, and mortality. Bacterial infections contribute substantially to severe exacerbations, while antimicrobial resistance complicates empirical antibiotic selection.
Objective:
To determine the prevalence of bacterial pathogens and their antimicrobial resistance patterns among patients with AECOPD admitted to the ICU of a tertiary care hospital in Uttarakhand.
Methods:
A retrospective observational study was conducted in the Department of Critical Care Medicine at a tertiary care hospital in Uttarakhand from July to December 2025. Data from 50 patients with AECOPD were reviewed. Respiratory specimens, including sputum, endotracheal secretions, and bronchoalveolar lavage (BAL), were evaluated for bacterial isolates and antimicrobial susceptibility patterns.
Results:
Among the 50 patients, 39 (78.0%) were male and 28 (56.0%) belonged to the 61–80-year age group. Endotracheal secretions and BAL each accounted for 18 (36.0%) specimens, while sputum accounted for 14 (28.0%). The predominant bacterial isolate was Acinetobacter baumannii (25/50, 50.0%), followed by Pseudomonas aeruginosa (20/50, 40.0%) and Klebsiella pneumoniae (5/50, 10.0%).
Conclusion:
Acinetobacter baumannii and Pseudomonas aeruginosa were the predominant bacterial isolates among ICU patients with AECOPD. Institutional antimicrobial resistance surveillance is essential for guiding appropriate antibiotic selection.
Recommendation:
Regular microbiological surveillance, periodic institutional antibiogram development, and culture-directed antibiotic therapy are recommended to guide appropriate antimicrobial selection and strengthen antimicrobial stewardship in ICU patients with AECOPD.
Referințe
1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2026 report. Fontana: GOLD; 2025.
2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2025 report. Fontana: GOLD; 2024.
3. Ullah MK, et al. Trends in the bacterial prevalence and antibiotic resistance patterns in the acute exacerbation of chronic obstructive pulmonary disease in hospitalized patients in South India. Antibiotics (Basel). 2022;11:1490. https://doi.org/10.3390/antibiotics11111577
4. Nguyen XD, Bui TT, Tran THT, et al. Spectrum and antimicrobial resistance in acute exacerbation of chronic obstructive pulmonary disease with pneumonia: a cross-sectional prospective study from Vietnam. BMC Infect Dis. 2024;24: Article 593. https://doi.org/10.1186/s12879-024-09515-6
5. Yu S, Yang T. Characteristics of pathogens of acute exacerbation of chronic obstructive pulmonary disease hospitalized patients: a retrospective study from 2010 to 2020. Pulm Med. 2025. https://doi.org/10.1155/pm/4025205
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 35th ed. CLSI supplement M100. Wayne: CLSI; 2025.
7. European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 15.0. Växjö: EUCAST; 2025.
8. Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2021. Intensive Care Med. 2021;47:1181-1247. https://doi.org/10.1007/s00134-021-06506-y
9. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: an official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med. 2019;200:e45-e67. https://doi.org/10.1164/rccm.201908-1581ST
10. National Centre for Disease Control. National treatment guidelines for antimicrobial use in infectious disease syndromes. Version 2.0. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2025.
11. World Health Organization. Global Antimicrobial Resistance and Use Surveillance System (GLASS) report: antibiotic use data for 2022. Geneva: World Health Organization; 2025. ISBN: 978-92-4-010812-7.
12. National Centre for Disease Control. National treatment guidelines for antimicrobial use in infectious disease syndromes: antimicrobial stewardship and culture-guided antibiotic selection in critically ill patients. New Delhi: Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2025.
Descărcări
Publicat
Număr
Secțiune
Licență
Copyright (c) 2026 Dr. Veena Boswal, Dr. Imliwati Aier, Dr. Puneet Tyagi, Dr. Rohit Kumar, Dr. Akash Seepal, MS. Ankita Saini

TAceastă lucrare este licențiată în temeiul Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.














